Last verified: 3 days ago
Bifidobacteria
Also known as: Bifidobacterium, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium breve, Bifidobacterium animalis, B. infantis, B. lactis, B. breve
Evidence under review. — Not yet rated
Beneficial gut bacteria shown to reduce antibiotic-related diarrhea, support immunity, and protect preterm infants.
-
What it does
Bifidobacteria are a group of beneficial bacteria that naturally live in the human gut, especially in infants. Clinical studies show they can reduce diarrhea caused by antibiotics in children,...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
No established dose — varies by strain and condition
-
Found in
What the Science Says
Bifidobacteria are a group of beneficial bacteria that naturally live in the human gut, especially in infants. Clinical studies show they can reduce diarrhea caused by antibiotics in children, lower the risk of a serious gut condition (necrotizing enterocolitis) in extremely premature infants, and help maintain a healthy gut microbiome during medical treatments like chemotherapy or bone marrow transplant. Early-life supplementation with specific strains alongside human milk oligosaccharides may also shape immune development in formula-fed infants.
What It Doesn't Do
Not a cure for any disease. Won't replace antibiotics or cancer treatment. Evidence for benefits in healthy adults is thin — most strong data comes from sick or vulnerable populations. No proof it helps with weight loss, energy, or mental clarity based on these studies. Not all strains are the same — a product with 'Bifidobacteria' on the label may use a strain with no clinical backing.
Evidence-Based Benefits
Reduces diarrhea in children taking amoxicillin by about 70% when the right strain is used.
Moderate EvidenceEffective at: No established dose from provided studies
Supporting studies (click to view on PubMed):
Cuts the risk of necrotizing enterocolitis nearly in half in extremely premature infants.
Moderate EvidenceEffective at: Multi-strain product (B. infantis Bb-02, B. lactis BB-12, S. thermophilus TH-4)
Supporting studies (click to view on PubMed):
Synbiotic with B. infantis and human milk oligosaccharides shapes immune development in formula-fed infants.
Moderate EvidenceEffective at: No established dose from provided studies
Supporting studies (click to view on PubMed):
Helps maintain gut microbiome diversity during high-risk medical treatments like bone marrow transplant.
Weak EvidenceEffective at: No established dose from provided studies
Supporting studies (click to view on PubMed):
Certain strains enhance immune markers like IgM and macrophage activity in animal models.
Weak EvidenceEffective at: 12.5–75 mg/kg body weight daily (mouse study)
Supporting studies (click to view on PubMed):
Absorption & Bioavailability
Unknown for most strains — survival through the GI tract varies by strain, formulation, and whether taken with food or prebiotics. Some strains (e.g., B. breve PRL2020) are specifically selected for antibiotic resistance to survive co-administration.
Red Flags to Watch For
- Strain specificity matters enormously — benefits shown for one strain (e.g., B. breve PRL2020) do not apply to all Bifidobacteria products
- Immunocompromised individuals face rare but real risk of probiotic-associated sepsis — one case (0.4%) was reported in extremely preterm infants
- Some commercial strains carry antibiotic resistance genes (e.g., tetW in B. animalis lactis) that could theoretically spread in the gut — a safety concern regulators are actively addressing
- Many products list CFU counts at manufacture, not at expiration — actual live bacteria at time of use may be far lower
- Most robust clinical evidence is in vulnerable populations (preterm infants, cancer patients, children on antibiotics) — benefits in healthy adults are not well established by these studies
Products Containing Bifidobacteria
See how Bifidobacteria is used in these analyzed products:
Frequently Asked Questions
What does Bifidobacteria do?
Beneficial gut bacteria shown to reduce antibiotic-related diarrhea, support immunity, and protect preterm infants.
What is the effective dose of Bifidobacteria?
No established dose — varies by strain and condition
Is Bifidobacteria safe?
Strain specificity matters enormously — benefits shown for one strain (e.g., B. breve PRL2020) do not apply to all Bifidobacteria products
What doesn't Bifidobacteria do?
Not a cure for any disease.
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-11-13